Literature DB >> 2005208

Lymphokines, including interleukin-2, alter gonadotropin-stimulated progesterone production and proliferation of human granulosa-luteal cells in vitro.

L J Wang1, S Robertson, R F Seamark, R J Norman.   

Abstract

The effects of human interleukin-1 (IL-1) and IL-2 on human granulosa-luteal cell progesterone production were examined with or without hCG stimulation in vitro. Human granulosa-luteal cells were recovered from follicular fluid obtained from women undergoing in vitro fertilization procedures and cultured for up to 7 days before supernatant progesterone level measurement. Lymphokine-rich conditioned medium was prepared from mitogen-stimulated human peripheral blood leukocytes (HPL-CM). The influence of HPL-CM on both granulosa-luteal cell progesterone production and cell growth was inhibitory. In contrast, supernatants of the IL-2-producing cell line MLA-144 (MLA-CM) stimulated both basal progesterone secretion and cell proliferation. Human recombinant IL-2 (from 0.1-100 IU) alone did not change progesterone levels, compared to control values, after 24 h of cell culture. However, 1, 10, and 100 IU IL-2 significantly inhibited progesterone secretion from cells stimulated by 5 IU hCG (P less than 0.01). The enhanced progesterone levels stimulated by forskolin were also significantly inhibited by 10 IU IL-2 (P = 0.01). This effect was not mediated through decreased cAMP, since the forskolin-enhanced cAMP level was not influenced by IL-2, IL-1, with or without hCG, did not show any effect on progesterone production during either 24 or 48 h of cell culture. It is concluded that 1) human recombinant IL-2 significantly inhibits progesterone production stimulated by hCG in human granulosa-luteal cells; 2) IL-2 also had a marked inhibitory effect on forskolin-induced progesterone release, but did not influence the increased cAMP level stimulated by forskolin; 3) the inhibitory influence of IL-2 on progesterone synthesis may be down-stream in the signal transduction pathway from cAMP activation; and 4) HPL-CM and MLA-CM produced inhibitory and stimulatory effects, respectively, on both basal and hCG-stimulated progesterone levels as well as on granulosa-luteal cell proliferation. These activities cannot be completely attributed to IL-2, and other mediators of leukocyte origin may, therefore, exist.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2005208     DOI: 10.1210/jcem-72-4-824

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

Review 1.  The human luteal paracrine system: current concepts.

Authors:  C Nappi; A R Gargiulo; C Di Carlo
Journal:  J Endocrinol Invest       Date:  1994-11       Impact factor: 4.256

2.  Cytokines in the human ovary: presence in follicular fluid and correlation with leukotriene B4.

Authors:  H Bili; B C Tarlatzis; M Daniilidis; A Fleva; J Bontis; A Tourkantonis; S Mantalenakis
Journal:  J Assist Reprod Genet       Date:  1998-02       Impact factor: 3.412

3.  Interleukin-2 affects steroidogenesis and numbers of bovine ovarian granulosa cells but not thecal cellsin vitro.

Authors:  C A Rajagopala Raja; L J Spicer; R E Stewart
Journal:  Endocrine       Date:  1995-12       Impact factor: 3.633

4.  Evidence that granulosa cells inhibit interleukin-1 alpha and interleukin-2 production from follicular lymphomonocytes.

Authors:  A Macciò; G Mantovani; E Turnu; P Artini; G Contu; F G Serri; A Volpe
Journal:  J Assist Reprod Genet       Date:  1993-11       Impact factor: 3.412

5.  Interleukin-1 beta, interleukin-6, and growth hormone levels in human follicular fluid.

Authors:  C Huyser; F L Fourie; E Bosmans; P F Levay
Journal:  J Assist Reprod Genet       Date:  1994-04       Impact factor: 3.412

6.  Short-term Western-style diet negatively impacts reproductive outcomes in primates.

Authors:  Sweta Ravisankar; Alison Y Ting; Melinda J Murphy; Nash Redmayne; Dorothy Wang; Carrie A McArthur; Diana L Takahashi; Paul Kievit; Shawn L Chavez; Jon D Hennebold
Journal:  JCI Insight       Date:  2021-02-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.